Kovitz Investment Group Partners, LLC Exelixis, Inc. Transaction History
Kovitz Investment Group Partners, LLC
- $28.6 Billion
- Q4 2024
A detailed history of Kovitz Investment Group Partners, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 19,653 shares of EXEL stock, worth $730,698. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,653
Previous 19,653
-0.0%
Holding current value
$730,698
Previous $654,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EXEL
# of Institutions
566Shares Held
251MCall Options Held
1.45MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.25 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.09 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$871 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$569 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$424 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...